Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Title:
Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Author:
Michikawa, Chieko Torres-Saavedra, Pedro A. Silver, Natalie L. Harari, Paul M. Kies, Merrill S. Rosenthal, David I. Le, Quynh-Thu Jordan, Richard C. Duose, Dzifa Y. Mallampati, Saradhi Trivedi, Sanchit Luthra, Rajyalakshmi Wistuba, Ignacio I. Osman, Abdullah A. Lichtarge, Olivier Foote, Robert L. Parvathaneni, Upendra Hayes, D. Neil Pickering, Curtis R. Myers, Jeffrey N.